Zafrens

Zafrens

Zafrens is a San Diego-based drug discovery company that has developed the Z-Screen platform, combining microfluidics, longitudinal cell imaging, and sequencing to rapidly test large numbers of potential medicines. The company aims to validate biological hypotheses faster than traditional methods by linking molecular data to cell function at high throughput. This funding will advance its internal drug pipeline and expand its screening platform.

Total raised
Undisclosed
tracked to date
Latest round
Series A
Nov 3, 2026
Known investors
2
led by Trill Impact

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q4 2026 USA Funding Report

Read the Q4 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q4-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q4 2026 USA Funding Report</a>

Funding history

  1. 1
    $6 million Series A extensionSeries ANov 3, 2026

    Led by Trill Impact

    Announcement ↗

Founder

Swamy Vijayan
Swamy Vijayan
Founder and chief executive officer

Investors in Zafrens

Backers from this company's tracked funding rounds.

Zafrens in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile